ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 96.30
-3.00 (-3.02%)
At close: Mar 11, 2026
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €7.5 billion as of March 11, 2026. Its market cap has increased by 1,613.76% in one year.
Market Cap
7.50B
Enterprise Value
6.98B
Revenue
5.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€96.30
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 7.50B, an increase of 3,608.16%. That is a compound annual growth rate of 40.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 7.50B | -20.02% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.59B |
| Inventiva | 1.09B |
| DBV Technologies | 1.08B |
| Valneva SE | 855.91M |
| MedinCell | 817.90M |
| Genfit | 466.08M |
| Cellectis | 243.74M |
| Transgene | 219.61M |